Improved survival rates linked to cancer treatment-induced hypothyroidism

10 May 2018


Hypothyroidism caused by tyrosine kinase inhibitors used in thyroid cancer treatment has been linked to longer survival rates, according to a study published in Thyroid.

Medscape


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story